Compass therapeutics to participate in the svb securities global biopharma conference

Boston, feb. 02, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the svb securities global biopharma conference, which is taking place virtually on february 13 – 16, 2023.
CMPX Ratings Summary
CMPX Quant Ranking